Holdings
TCG Crossover Management, LLC
As of Jun 30, 2026, TCG Crossover Management, LLC reported 49 positions worth US$4.02B. Largest: Abivax Sa, Tango Therapeutics, Inc. and Cg Oncology, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Abivax Sa | 6.01M | US$801M | −473K | Jun 30, 2026 |
| Tango Therapeutics, Inc. | 9.08M | US$284M | −1.45M | Jun 30, 2026 |
| Cg Oncology, Inc. | 3.67M | US$261M | no change | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 4.85M | US$188M | −92,458 | Jun 30, 2026 |
| Immunovant, Inc. | 4.46M | US$172M | no change | Jun 30, 2026 |
| Spyre Therapeutics, Inc. | 1.9M | US$169M | no change | Jun 30, 2026 |
| Dianthus Therapeutics, Inc. | 1.68M | US$163M | no change | Jun 30, 2026 |
| Mirum Pharmaceuticals, Inc. | 1.06M | US$124M | no change | Jun 30, 2026 |
| Zai Lab Ltd. | 6.14M | US$117M | new | Jun 30, 2026 |
| Amylyx Pharmaceuticals, Inc. | 6.24M | US$112M | no change | Jun 30, 2026 |